Profiling the Symptom Burden of Patients with Metastatic NSCLC Receiving Either Chemotherapy or Targeted Therapy: Real-World Data

被引：0

作者：

Shi, Q. ^{[1
]}

Williams, L. ^{[1
]}

Vaghani, V. ^{[2
]}

Hirschmann, M. ^{[2
]}

Landry, L. L. ^{[2
]}

Roarty, E. ^{[2
]}

Zhang, J. ^{[2
]}

Rinsurnogkawong, W. ^{[3
]}

Lewis, J. ^{[3
]}

Cleeland, C. ^{[1
]}

Lee, J. ^{[3
]}

Roth, J. A. Jack A. ^{[4
]}

Swisher, S. ^{[5
]}

Heymach, J. ^{[2
]}

Simon, G. ^{[6
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Symptom Res, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Quantitat Reasearch Comp, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Thorac & Cardiovasc Surg, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Thorac Med Oncol, Houston, TX 77030 USA

来源：

关键词：

longitudinal symptom profiles; Targeted therapy; Patient-reported outcomes;

D O I：

10.1016/j.jtho.2018.08.1141

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.01-87

引用

页码：S698 / S698

页数：1